Últimas noticias sobre Pursuit Attractions (NYSE:PRSU) Bolsa

Pursuit Attractions

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

Levi Strauss

News

Pre-Market Outlook

Markets

Movers

AREB

BJDX

CHSN

CVRX

GLXG

GRFX

IPDN

IVDA

KNOP

KPTI

LEVI

PRSU

SOBR

STTK

SVRE

Levi sorprende al mercado con ganancias trimestrales mejores de lo esperado y una perspectiva 2025 que mantiene sin cambios.

Acciones de Levi Strauss suben un 10%; Aquí están 20 acciones que se mueven en el premercado de EE. UU.

Pursuit Attractions and Hospitality, Inc. Common Stock

Pursuit Attractions and Hospitality Inc

WIIM

LeanDepot shares are trading higher. UBS raised its price target on the stock from $1.25 to $1.4.

Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) shares are trading higher Wednesday following positive analyst coverage from JPMorgan. Here&#8217;s what you need to know.
What To Know: JP Morgan analyst Cory Carpenter maintained an Overweight rating on Roblox on Wednesday and raised the price target from $120 to $125.
JPMorgan&#8217;s $125 target is the Street-high for Roblox. The consensus target currently sits at $83.70, according to <a href="https://www.benzinga.com/quote/RBLX/analyst-ratings">Benzinga data</a>.
The analyst update comes after Roblox announced the launch of its new licensing platform on Tuesday.
The new platform enables rights holders to offer intellectual property for creators to integrate into their experiences in days instead of months. At launch, the catalog features titles from Lionsgate, Netflix, Sega and Kodansha, including&nbsp;Stranger Things,&nbsp;Squid Game,&nbsp;Twilight,&nbsp;Saw and&nbsp;Like a Dragon.
Analysts have been growing more bullish on Roblox in recent weeks. Notable moves this month include Citigroup, which maintained a Buy rating and raised its price target from $100 to $123, and BTIG, which also maintained a Buy and lifted its target from $73 to $124.
Roblox has a strong momentum score of 97.33, according to Benzinga Edge rankings. The stock has more than doubled over the past three months.
Related Link: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46451165/travelers-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Travelers Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
RBLX Price Action: At the time of writing, Roblox shares are trading 6.44% higher at $119.76, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
image via Shutterstock

RBLX

Roblox Stock Is Moving Higher Wednesday: What's Going On?

<a href="https://x.com/marcorubio/status/1945554584878911761" title="https://x.com/marcorubio/status/1945554584878911761">https://x.com/marcorubio/status/1945554584878911761</a>

Macro Economic Events

Politics

Global

Economics

General

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Commenting On Israel-Syria Attacks, Marco Rubio Posts On X "We have engaged all the parties involved in the clashes in Syria. We have agreed on specific steps that will bring this troubling and horrifying situation to an end tonight. This will require all parties to deliver on the commitments they have made and this is what we fully expect them to do."

Fair Isaac Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) stock came under pressure on last week's announcement of Fannie Mae (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FNMA#OTC">FNMA</a>) and Freddie Mac (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FMCC#OTC">FMCC</a>) are now accepting VantageScore 4.0, which caused investor concerns around an erosion of the "FICO monopoly," according to Needham.
The Fair Isaac Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f22a54029cf490001b01b94/kyle-peterson">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f22a54029cf490001b01b94/kyle-peterson">Kyle Peterson</a> maintained a Buy rating, while reducing the price target from $2,575 to $1,950.
The Fair Isaac Thesis: The company has "numerous levers," including auto scores pricing, repurchasing shares and streamlining expenses in its software business, which could enable it to drive over 20% earnings growth, Peterson said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
While FICO Scores are no longer being mandated for lenders is a "big negative" for Fair Isaac, not many lenders may actually adopt VantageScore, as "infrastructure changes will need to be made," the analyst stated. 
Also, mortgage credit scores are typically passed onto the consumer and constitute a minute percentage of closing costs, she added.
Fair Isaac's market share losses in mortgage due to the announcement are likely to be "minimal," Peterson said. The stock is still a "high-quality information services asset" and continues to be in the Needham Conviction List, she further wrote.
FICO Price Action: Shares of Fair Isaac had risen by 1.41% to $1,528.41 at the time of publication on Wednesday.
Read More: • <a href="https://www.benzinga.com/news/entertainment/25/07/46371957/netflixs-squid-game-reality-show-gets-season-2-date-4-56-million-prize-without-the-killing">Cramer Says Okta Is Solid—But There&#8217;s One Cybersecurity Stock He Prefers</a>

Analyst Color

Government

Price Target

Reiteration

Analyst Ratings

Real Estate

FICO

FMCC

FNMA

Will Fair Isaac's FICO Score Lose Market Share Due To VantageScore?

Lake Street analyst Frank Takkinen initiates coverage on AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) with a Buy rating and announces Price Target of $24.

Initiation

ANGO

Lake Street Initiates Coverage On AngioDynamics with Buy Rating, Announces Price Target of $24

LNTH

Lantheus Holdings shares are trading lower after US health agencies proposed changes to Medicare payment rules for hospital outpatient services and surgical centers starting in 2026.

Shares of private-equity and private market asset managers are trading higher following reports that President Trump will sign an executive order enabling easier U.S. retirement plan investment into private assets.

Reuters Cites U.S. Secretary Of State Rubio Saying We Have Agreed On Specific Steps That Will Bring Syria Situation To An End Tonight

Lantheus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) shares fell Wednesday after U.S. health agencies proposed changes to Medicare payment rules for <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">hospital outpatient services</a> and surgical centers starting in 2026.
The proposal <a target="_blank" href="https://public-inspection.federalregister.gov/2025-13360.pdf?" rel="noreferrer noopener">outlines</a> changes in how payment rates are calculated for services under the Hospital Outpatient Prospective Payment System (OPPS) and the ASC payment system.
The CMS has proposed maintaining the $140 packaging threshold for drugs, biologicals, and therapeutic radiopharmaceuticals for calendar year (CY) 2026 under the OPPS and ASC payment system.
Also Read: <a href="https://www.benzinga.com/25/01/43273980/lantheus-to-buy-evergreen-theragnostics-for-over-1-billion-to-bolster-its-cancer-radiopharmaceutical-portfolio" target="_blank" rel="noreferrer noopener">Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio</a>
This threshold reflects inflationary adjustments based on the four-quarter moving average of the Producer Price Index (PPI) for prescription pharmaceuticals.
The $140 figure traces back to the $50 threshold established initially under section 1833(t)(16)(B) of the Social Security Act for CYs 2005 and 2006.
CMS first updated this in CY 2007 by trending the $50 forward to CY 2007 using PPI data, rounding it to the nearest $5, and arriving at $55. The same methodology has since been used to update the packaging threshold, including for the CY 2025 rule.
For CY 2026, CMS again applied the same approach, using forecasted PPI data from IHS Global Inc. (IGI), yielding a proposed figure of $141.67, which was rounded to $140.
Additionally, CMS proposes setting the diagnostic radiopharmaceutical packaging threshold at $655 for CY 2026.
This reflects an inflation-adjusted increase from the finalized $630 threshold for CY 2025, using the most recent four-quarter moving average PPI data from the third quarter of 2025 to the third quarter of 2026.
The resulting figure of $654.23 was rounded to the nearest $5.
CMS finalized in the CY 2025 OPPS/ASC final rule that diagnostic radiopharmaceuticals would be paid separately if their per-day cost exceeds the packaging threshold of $630 for that year.
CMS noted that if more recent data becomes available before the CY 2026 final rule is published, the agency may revise the $140 drug packaging threshold and the $655 diagnostic radiopharmaceutical threshold accordingly.
William Blair &#8220;believes that Lantheus shareholders will be disappointed by CMS's proposal, especially given that Lantheus management has conveyed the potential for CMS to transition to ASP pricing, which would positively impact the Pylarify franchise.&#8221;
Analyst Andy Hsieh on Tuesday said with the CMS finalizing rules on how diagnostic radiopharmaceuticals are reimbursed, concerns around Pylarify losing its pass-through status—and revenue stability—<a target="_blank" href="https://www.benzinga.com/quote/LNTH/analyst-ratings" rel="noreferrer noopener">have eased</a>.
The changes mean Pylarify's Medicare-related business should remain largely unaffected, and its leading market position is expected to stay intact.
That said, due to ongoing challenges in securing long-term contracts with partners, Pylarify's growth may stay modest in the short term. Stronger growth likely won't pick up until the second half of the year.
Meanwhile, the company's profitability from its Alzheimer's portfolio depends heavily on how well its commercial products perform.
Price Action: LNTH stock is down 7.77% at $74.95 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/fda/25/07/46447668/fda-lifts-pause-on-kezars-liver-drug-trial-next-stop-lupus-study" target="_blank" rel="noreferrer noopener">FDA Lifts Pause On Kezar&#8217;s Liver Drug Trial—Next Stop Lupus Study</a></li>
</ul>
Image: Shutterstock

Health Care

Trading Ideas

Why Is Lantheus Stock Trading Lower On Wednesday?

In an economy where investors seek income but are wary of interest rate risk, Global X&#8216;s <a href="https://www.benzinga.com/etfs">newest ETF is betting</a> that Treasuries can deliver both.
The new Global X Treasury Bond Enhanced Income ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/TLTX#BATS">TLTX</a>) seeks to maximize U.S. government bond debt through the addition of a tactical twist: weekly writing of covered calls. The fund leverages both classic exposure to Treasuries and Treasury STRIPS, as well as short-duration options on Treasury ETFs, to generate premium income that mitigates the impact of interest rate increases.
Also Read:<a href="https://www.benzinga.com/etfs/new-etfs/25/07/46449274/jpmorgan-goes-global-with-hola-etf-stocks-plus-built%E2%80%91in-crash-protection"> JPMorgan Goes Global With HOLA ETF—Stocks Plus Built‑In Crash Protection</a>
In contrast to traditional bond funds, which rely solely on yield, TLTX proactively manages interest-rate sensitivity and seeks to smooth returns without compromising upside potential in a segment of its portfolio.
Pedro Palandrani, Global X&#8217;s Head of Product Research &amp; Development explained that premiums from weekly call options can offset drawdowns during volatile rate periods.
The launch is a continuation of Global X&#8217;s push into options-enhanced ETFs. The firm now has 15 covered call products with TLTX. Through June 30, 2025, Global X&#8217;s covered call suite had amassed over $21 billion in assets under management.
<h2 class="wp-block-heading">TLTX Fund Snapshot:</h2>
<ul class="wp-block-list">
<li>Strategy: Treasuries + weekly covered calls</li>
<li>Payout Frequency: Monthly</li>
<li>Expense Ratio: 0.29%</li>
<li>Structure: Actively managed</li>
</ul>
The hybrid structure of the fund exposes investors to a well-established asset class, U.S. Treasury bonds, while also tapping into a potential secondary income source through options. And by writing calls on only half of the portfolio, TLTX retains flexibility for capital gain, setting it apart from funds that fully take in upside in exchange for yield.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/07/46449577/bet-like-a-billionaire-new-etfs-mimic-hedge-fund-moves-but-for-less">Bet Like A Billionaire: New ETFs Mimic Hedge Fund Moves, But For Less</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

TLTX

Can Treasuries Pay You Like Stocks? Global X Thinks So With The New TLTX ETF

DA Davidson analyst Jeff Rulis maintains Equity Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQBK#NYSE">EQBK</a>) with a Neutral and raises the price target from $39 to $44.

EQBK

DA Davidson Maintains Neutral on Equity Bancshares, Raises Price Target to $44

DA Davidson analyst Gary Tenner maintains Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) with a Buy and raises the price target from $65 to $67.

DA Davidson Maintains Buy on Hancock Whitney, Raises Price Target to $67

Humana Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) is consolidating on Wednesday. But it may be about to <a href="https://www.benzinga.com/markets/large-cap/25/06/45796533/humana-backs-reforms-to-limit-medicare-advantage-billing-practices">reverse and rally</a>.
It is oversold and getting close to a support level, and these are bullish dynamics that could set the stage for a move higher. This is why it is the Stock of the Day.
Many trading strategies and styles are based on the concept of reversion to the mean. If a stock gets overextended in one direction, there is a good chance it reverses and heads back in the other direction.
Most of the time, a stock stays within its typical or usual trading range. If the sellers get aggressive and emotional, pushing the price below this range, the stock is said to be oversold.
This will draw buyers into the market, who will expect a reversion to the mean or a move higher. Their buying could become a self-fulfilling prophecy. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="581" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16143606/Humana.one_-1024x581.png" alt="" class="wp-image-988443" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16143606/Humana.one_-1024x581.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16143606/Humana.one_-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16143606/Humana.one_-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/16143606/Humana.one_.png 1455w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46438576/nvidia-is-on-a-march-to-5-trillion-market-capitalization-says-dan-ives-as-he-predicts-bullish-environment-for-tech-and-crypto-very-strong-second-half">Nvidia Is &#8216;On A March To $5 Trillion&#8217; Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: &#8216;Very Strong Second Half&#8217;</a>
There are many ways to determine if a stock is oversold. One popular indicator is called the stochastic, which is on the lower part of the chart.
If the red and blue lines are at the lower end of the range, it indicates oversold conditions. As you can see, that's the case now.
Humana is also getting close to a level that has been support previously. This could also be bullish.
Support levels can stay intact for a long time due to remorseful sellers. These are people who sold their shares while they were at support, who came to regret doing so after the price rallied.
Some vow to buy their shares back if they could eventually get them for the same price they were sold. So, when the stock drops back to the price that had been support, these regretful sellers place buy orders.
If there is a large number of these buy orders, it could create support at the level again. The combination of being oversold and at support could set the stage for a move higher for Humana.
Read Next: • <a href="https://www.benzinga.com/markets/economic-data/25/07/46440481/producer-prices-rise-less-than-expected-inflation">June Producer Prices Flat—Is Inflation Finally Cooling?</a>
Photo by T. Schneider via Shutterstock

Technicals

Stock Of The Day: Is It Time To Buy Humana?

DA Davidson analyst Rudy Kessinger maintains CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) with a Buy and lowers the price target from $215 to $200.

CVLT

DA Davidson Maintains Buy on CommVault Systems, Lowers Price Target to $200

Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is reportedly preparing to introduce a longer, six-seat version of its Model Y sport utility vehicle in China.
The news comes after Tesla reported a&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/asia/25/07/46289899/tesla-china-sales-plunge-over-75-in-first-week-of-july-despite-strong-q2-deliveries" rel="noreferrer noopener">75% plunge in sales</a>&nbsp;in China during the first week of July as the company recorded<a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46409821/tesla-rebounds-in-china-with-12-3k-weekly-registrations-highest-2nd-week-ever" rel="noreferrer noopener"> 5,010 insured registrations.</a>
Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-16/tesla-readies-a-six-seat-version-of-the-model-y-suv-for-china" rel="noreferrer noopener">reports</a>, citing data from the Ministry of Industry and Information Technology&#8217;s <a target="_blank" href="https://www.miit.gov.cn/datainfo/cpgg/art/2025/art_4efe58701e4b4d3da9d1ff4b0ad9951f.html" rel="noreferrer noopener">website</a>, that the vehicle will be about 150 centimeters (5.9 inches) longer than the existing Model Y.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/07/46432467/tesla-stock-slides-amid-executive-departure-intensifying-scrutiny-on-self-driving-tech" rel="noreferrer noopener">Tesla Stock Slides Amid Executive Departure, Intensifying Scrutiny On Self-Driving Tech</a>
Battery supplier LG New Energy is listed in the filing, indicating its role in powering the vehicle, the report adds.
According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, TSLA stock has gained over 24% in the past year, but it&#8217;s down over 15.7% year to date. Investors can gain exposure to the stock via Simplify Volt TSLA Revolution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TESL#NYSE">TESL</a>) and Roundhill ETF Trust Roundhill TSLA WeeklyPay ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/TSLW#BATS">TSLW</a>).
Future Fund LLC&#8217;s managing director, Gary Black, recently hailed Tesla&#8217;s sales in the Chinese domestic market as <a href="https://www.benzinga.com/markets/tech/25/07/46409821/tesla-rebounds-in-china-with-12-3k-weekly-registrations-highest-2nd-week-ever" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s EV maker gains momentum.</a>
The investor took to social media platform X on Tuesday to share the data in a post. &#8220;Tesla China reported a strong 12.3K insured registrations for the week of July 7-13,&#8221; he said in his post.
The investor added that the figures indicated it was the &#8220;highest second week&#8221; of the quarter of all time for Tesla in China. &#8220;After two weeks. 3Q is +92% QoQ and -3% YoY,&#8221; Black said in the post.
Still, BYD (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) <a href="https://www.benzinga.com/markets/tech/25/06/45969242/elon-musk-has-a-new-problem-byd-beats-tesla-in-global-ev-sales-amid-europe-expansion">recently surpassed</a> Tesla in global battery electric vehicle (BEV) sales, according to the International Council on Clean Transportation. It also reported annual revenue of 777 billion yuan ($107 billion) for 2024, surpassing Tesla.
Tesla will sell the Model Y rear-wheel drive trim in India for over 6 million Indian National Rupees (INR) or approximately $70,000, according to a listing on <a href="https://www.benzinga.com/markets/tech/25/07/46407991/elon-musks-tesla-to-sell-model-y-from-70000-in-india-launches-first-showroom-in-mumbai" target="_blank" rel="noreferrer noopener">Tesla&#8217;s official Indian website.</a>
Tesla will also offer the Model Y long-range rear-wheel drive will retail for 6.8 million INR (roughly $79,000). The company will also offer FSD or Full Self-Driving in the country for an additional 600,000 INR, or approximately $7,000.
Price Action: TSLA shares are trading higher by about 3% to $320 at last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46446903/why-nvidias-huang-would-be-thrilled-to-own-a-xiaomi-ev" target="_blank" rel="noreferrer noopener">Why Nvidia&#8217;s Huang Would Be Thrilled To Own A Xiaomi EV</a></li>
</ul>
Image: Shutterstock

Equities

BYDDF

BYDDY

TESL

TSLA

TSLW

What's Going On With Tesla Stock On Wednesday?

<a href="https://www.theinformation.com/articles/investors-float-deal-valuing-anthropic-100-billion" title="https://www.theinformation.com/articles/investors-float-deal-valuing-anthropic-100-billion">https://www.theinformation.com/articles/investors-float-deal-valuing-anthropic-100-billion</a>

AMZN

GOOG

GOOGL

'Investors Float Deal Valuing Anthropic at More Than $100 Billion' - The Information

Google-parent Alphabet Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) strategic position and <a>tech-first </a>corporate culture drive upside to the stock valuation, according to Needham.
The Alphabet Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580607ae846faa000106ab43/laura-martin">Analyst Laura Martin</a> maintained a Buy rating, while raising the price target from $178 to $210.
The Alphabet Thesis: The latest labor productivity trends indicate that the company's execution is improving, Martin said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The analyst mentioned four reasons for potential upside to the stock valuation:
<ul class="wp-block-list">
<li>Google Search was among the top three beneficiaries of the internet tech wave</li>
<li>The company's Android was one of the two biggest beneficiaries of the mobile tech wave</li>
<li>Google Cloud was among the top three beneficiaries of the Cloud tech wave</li>
<li>Alphabet's Gemini is poised to be one of the top four biggest winners of the GenAI tech wave</li>
</ul>
She further wrote, "What other company at a 17x P/E, has the assets AND a tech-first corp culture with this track record across all four major tech waves of the past 30 years?"
GOOGL Price Action: Shares of Alphabet had risen by 1.06% to $183.94 at the time of publication on Wednesday.
Read More: <a href="https://www.benzinga.com/news/entertainment/25/07/46371957/netflixs-squid-game-reality-show-gets-season-2-date-4-56-million-prize-without-the-killing"> </a> • <a href="https://www.benzinga.com/news/entertainment/25/07/46371957/netflixs-squid-game-reality-show-gets-season-2-date-4-56-million-prize-without-the-killing">AAPL &#8216;Stock Would Soar&#8217; If It Buys This, Says Jim Cramer: &#8216;Continued Buybacks Will Do Nothing&#8217;</a>
Photo: Shutterstock

Tech

Alphabet Has Assets, Corporate Culture To Drive Valuation Higher, Says Bullish Analyst

Maxim Group analyst Jason McCarthy maintains SELLAS Life Sciences Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLS#NASDAQ">SLS</a>) with a Buy and raises the price target from $4 to $7.

Maxim Group Maintains Buy on SELLAS Life Sciences Gr, Raises Price Target to $7

Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares dipped after the banking giant reported mixed second-quarter 2025 earnings. While the company surpassed analyst expectations for earnings per share and revenue, a significant downward revision in its full-year net interest income (NII) forecast, a key profitability metric, raised investor concerns. 
This adjustment, driven by a weaker performance in its Markets division, overshadowed otherwise solid results and drew comparisons to the robust performance of peers like JPMorgan Chase &amp; Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>).
Wells Fargo reported a NII of $11.71 billion on Tuesday, down 2% year over year in the&nbsp;<a href="https://www.benzinga.com/markets/earnings/25/07/46414749/wells-fargos-net-interest-income-shrinks-in-q2-bank-trims-outlook" target="_blank" rel="noreferrer noopener">second quarter of 2025</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/financing/25/07/46213890/wall-streets-100-billion-payout-parade-jpmorgan-morgan-stanley-goldman-lead-capital-return-wave-af" rel="noreferrer noopener">Wall Street&#8217;s $100 Billion Payout Parade: JPMorgan, Morgan Stanley, Goldman Lead Capital Return Wave After Acing Fed&#8217;s 2025 Stress Test</a>
The bank reported earnings of $1.60 per share, beating the consensus of $1.40. &nbsp;Revenue increased 1% year over year to $20.82 billion. Analysts <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">expected $20.78 billion</a>.
Lower NII was driven by the impact of lower interest rates on floating rate assets and deposit mix changes, partially offset by lower market funding and deposit pricing.
For fiscal year 2025, Wells Fargo expects NII to be roughly in line with the 2024 income of $47.7 billion. In April, Wells Fargo&nbsp;expected NII to be ~1 to 3% higher than the 2024 NII <a href="https://www.benzinga.com/news/earnings/25/04/44759629/wells-fargo-doesnt-change-outlook-but-ceo-expects-volatility-and-slower-economic-environment-in-2025" target="_blank" rel="noreferrer noopener">of $47.7 billion</a>.
In stark contrast to Wells Fargo&#8217;s NII headwinds, UBS analyst Erika Najarian commented, &#8220;JPMorgan (JPM) flexes its revenue muscle yet again.&#8221; The banking behemoth reported adjusted EPS of $4.96, beating consensus estimates of $4.48 in the second quarter of 2025.
Managed net Revenue fell 10% year over year to $45.68 billion. Reported net Revenue declined 11% to $44.91 billion, topping the consensus estimate of $44.17 billion.&nbsp;
In a comparative analysis, UBS stated on Tuesday, &#8220;By contrast, we think WFC has &#8216;tough comps&#8217; to JPM results. WFC reported &#8216;core&#8217; EPS of $1.46, excluding a 6-cent gain on the acquisition of the remaining interest in a merchant services JV, and normalizing out an 8-cent tax benefit vs. expectations.&#8221;
Delving deeper into Wells Fargo&#8217;s NII performance, Najarian highlighted that Wells Fargo&#8217;s NII fell 3 cents below Wall Street expectations due to a slight 3-basis-point reduction in its net interest margin (NIM).
Najarian further noted that, as many investors anticipated, Wells Fargo reduced its full-year NII forecast to match last year&#8217;s $47.7 billion, largely due to the weaker Markets division performance being offset by higher fees. 
The analyst stated, &#8220;While the NII revision lower was largely anticipated and negative positioning here appears highly consensus, we still expect shares to open weaker given upward revisions at JPMorgan Chase and decent recent stock performance coming into the print.&#8221;
Consequently, analyst estimates are likely to be lowered by about $150 million, or roughly 3 cents per share. While core fee income was largely in line with expectations and expenses came in slightly better (about 1 cent lower), the overall expense outlook remains unchanged.
The analyst also commented on the market&#8217;s anticipation regarding Wells Fargo&#8217;s capital allocation following its strong stress test results. 
&#8220;We think the market is also seeking more color on how WFC plans to &#8216;spend&#8217; its capital windfall from solid stress test results, but we don&#8217;t anticipate much specific color from management on buybacks, which would support weakness in the stock if given,&#8221; the analyst said. 
Price Action: WFC stock is trading lower by 0.82% to $79.51 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46438576/nvidia-is-on-a-march-to-5-trillion-market-capitalization-says-dan-ives-as-he-predicts-bullish-environment-for-tech-and-crypto-very-strong-second-half" target="_blank" rel="noreferrer noopener">Nvidia Is &#8216;On A March To $5 Trillion&#8217; Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: &#8216;Very Strong Second Half&#8217;</a></li>
</ul>
Photo via Shutterstock

Earnings

Large Cap

Guidance

JPMorgan Flexes Revenue Muscle Again As Wells Fargo Battles NII Woes

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has surged over 25% over the past seven days, fueling bullish momentum as traders look for new all-time highs soon.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
<td>Market Cap</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$3.02</td>
<td>&nbsp;$178.9 billion</td>
<td>+27.1%&nbsp;</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$119,113.54</td>
<td>&nbsp;$2.4 trillion</td>
<td>+9%&nbsp;</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,314.22</td>
<td>&nbsp;$400.5 billion</td>
<td>+24.6%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto chart analyst Ali Martinez says XRP must secure a weekly close above $3 to kick off a move toward $4.80, which would mark a new all-time high.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A weekly close above $3 could send <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> to a new all-time high of $4.80! <a href="https://t.co/fvvq0EpW6j">pic.twitter.com/fvvq0EpW6j</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1945421650574323990?ref_src=twsrc%5Etfw">July 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Galaxy <a href="https://x.com/galaxyBTC/status/1945337859977687541">noted</a> XRP's tendency to retest its previous all-time high, consolidate just below it, and then break through into full price discovery. According to him, $3.30 remains the level to beat for the real rally to begin.
Veteran trader DonAlt, who first <a href="https://x.com/CryptoDonAlt/status/1945375562286895284">called</a> XRP when it was under $0.70, says the setup is aligning once again. 
If it clears $3.30 like last time, this next leg could be even stronger, he concluded.
Statistics: Coinglass data shows XRP open interest hit all-time highs on July 15, with an 8.8% spike in the past 24 hours. Liquidations totaled $7.99 million, with shorts accounting for $4.36 million, indicating strong upward pressure forced many bearish bets to close.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46437542/are-you-up-on-your-bitcoin-eth-xrp-holdings-take-out-enough-prominent-whale-cautions">Are You Up On Your Bitcoin, ETH, XRP Holdings? &#8216;Take Out Enough,&#8217; Prominent Whale Cautions</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Surges 25% In 1 Week: Here's When It Will Hit A New All-Time High

Press Releases

Pursuit Celebrates New Chapter by Ringing NYSE Opening Bell on January 7, 2025

Pursuit Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jasper Receives $5.5 million Donation Pledge to Support Long Term Recovery

Pursuit Announces New Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Pursuit Reports 2024 Fourth Quarter and Full Year Results

Pursuit Strengthens Leadership Team with Appointment of Cathy Tang as Chief Legal Officer & Corporate Secretary

Pursuit Announces Date for First Quarter 2025 Earnings Release and Conference Call

Pursuit Reports 2025 First Quarter Results

Pursuit Appoints New Chief Accounting Officer

Pursuit Expands Global Portfolio with Acquisition of Tabacón Thermal Resort & Spa in Costa Rica

Comments

Pursuit Attractions

Noticias

Últimas noticias sobre Pursuit Attractions (NYSE:PRSU) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL